Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Primary Care

 

TPG creates European outpatient real estate platform from €400m worth of MOBs bought from Northwest

Private equity investor TPG has launched a specialist outpatient real estate investment platform to hold the €400 million worth of German and Dutch medical outpatient buildings (MOBs) it bought from Canada-based healthcare REIT Northwest in January, and acquire similar additional properties. The platform, called Arcura Medical Properties, will remain fully owned by TPG’s real estate investment branch (TPG Real Estate), but will operate “independently”, managed by Simon Betty as CEO, who formerly headed Northwest’s European branch, along with his team.

Bupa acquires Australia’s Partnered Health Group

British multinational health insurer Bupa is acquiring Australian integrated healthcare provider Partnered Health Group from private equity firm Quadrant Private Equity. Bupa’s acquisition of Partnered Health reflects a broader shift among health insurers towards vertical integration, as payors look to move beyond the traditional model of reimbursing medical costs and take a more active role in delivering care. 

HBI 2026: Healthcare Property Summit

Speakers at the ‘Healthcare Property Summit’ at HBI 2026 expressed qualified optimism about the state of Europe’s healthcare real estate market. The record €21 billion inflow the continent saw in 2025, boosted by US healthcare REIT Welltower’s ~€8 billion investment into the UK’s care sector, “clearly shows confidence that the market is back,” as Nicolas Sannier, EMEA Healthcare Lead - Valuation & Risk at real estate services firm JLL, put it.

2026 will see modest growth and selective mega deals — Interview with Matthew Edwards, Osborne Clarke

Healthcare and life sciences deal activity is expected to pick up in 2026, following trends seen in 2025 when the market remained steady despite regulatory challenges, according to a recent report from global law firm Osborne Clarke. HBI spoke to Matthew Edwards, Partner at Osborne Clarke, to explore these developments and what they could mean for healthcare and life sciences transactions in 2026.

Greek bank Piraeus interested in Bioiatriki to form integrated payor-provider

Piraeus, Greece’s largest bank, has approached Bioiatriki, Greece’s largest for-profit primary care group, with the intention of acquiring it and integrating it with the insurer it bought last year, Ethniki Insurance, to form a major payor-provider which would become the largest for-profit healthcare provider in the country. 

Interview: Andy Scaife, SSP Health

SSP Health is one of only a handful of corporately-run primary care chains in the UK. It was founded in 2002 by two GP partners, Dr. Shikha Pitalia and Dr. Sanjay Pitalia, who are married. It has since grown to 45 practices, most of which are located in the North West of England.

Australia’s largest health insurer Medibank buys primary care chain Better Medical

Medibank, the largest private health insurer in Australia, is buying Better Medical, a 61-clinic primary care chain, from private equity firm Livingbridge, for A$159 million (~$103 million). This is part of a wider trend of vertical consolidation by insurers within Australia’s private healthcare market, which is raising concerns amongst many in the sector that it could lead to harmful cost cutting.

CMA greenlights PHP/Assura merger

The UK’s competition authority (the CMA) has decided to allow the merger of Assura and Primary Healthcare Properties (PHP), the only two major UK healthcare REITs focused on primary care clinics, bringing the creation of a giant primary care REIT holding about £6 billion (~€7 billion) worth of property and about 20% of the UK’s primary care practices one step closer to realisation. 

What Eko Health’s AI stethoscope can teach us about AI adoption in healthcare

An AI-powered digital stethoscope developed by a California-based medtech company called Eko Health has been found to detect heart conditions with significantly greater sensitivity than doctors using analogue stethoscopes in a trial with 200 UK GP practices. But the same study also found that 70% of these GP surgeries had stopped using them or were only using them infrequently a year after they were given them. In a conversation with HBI, Alfred Olivares and Nick Kovacev, who work for US technology consultancy HTEC, suggested some of the reasons for this, and the broader lessons for health tech companies trying to develop impactful AI tools.

Find Us